“Rapid Itch Relief With Upadacitinib Vs Dupilumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b 4 Level Up Study”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s735, https://doi.org/10.25251/078a3s70.